Human Pheromone Sciences, Inc. (HPS) has filed a comprehensive patent application with the International Bureau of the World Patent Office for the use of its innovative and previously undeveloped compound with its origin in sea coral, which has significant emotional impacts on both men and women, according to the company.

Prior to its reproduction of this compound, it could only be found in coral reefs off the coasts of Newfoundland and in the waters off Brazil's Guiabinha Island, says HPS.

The company has previously been granted broad-based worldwide patents for its initial compound, androstadienone, which has been licensed to leading marketers, including Johnson & Johnson, Avon and Schwarkopf and Henkel and its affiliates.

An HPS spokesperson indicated that the company believes that this additional filing on its new compound should be of interest to the major consumer products companies around the world.